{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:12:24Z","timestamp":1783746744233,"version":"3.55.0"},"reference-count":94,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1297\/cpe.2026-0005","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T22:09:01Z","timestamp":1774476541000},"page":"201-214","source":"Crossref","is-referenced-by-count":0,"title":["Hematopoietic stem cell transplantation-associated partial lipodystrophy"],"prefix":"10.1297","volume":"35","author":[{"given":"Masanori","family":"Adachi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Showa Medical University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rotz, SJ, Bhatt, NS, Hamilton, BK, Duncan, C, Aljurf, M, Atsuta, Y, et al. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: A 2023 Update. Transplant Cell Ther 2024;30: 349\u201385.","DOI":"10.1016\/j.jtct.2023.12.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bhatt, NS, Richards, A, Beebe, KL, Khera, N. Challenges and opportunities in the care of hematopoietic cell transplant survivors in the modern era. Adv Exp Med Biol 2025;1475: 209\u201326.","DOI":"10.1007\/978-3-031-84988-6_12"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lee, SL, Nguyen, QN, Ho, C, James, S, Kaur, A, Lim, A, et al. The late effects of hematopoietic stem cell transplants in pediatric patients: a 25-year review. J Clin Endocrinol Metab 2025;110: e347\u201362.","DOI":"10.1210\/clinem\/dgae196"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jeon, MJ, Noh, E, Moon, SJ, Yu, ES, Choi, CW, Kim, DS, et al. Long-term psychiatric and endocrine complications following hematopoietic stem cell transplantation in hematologic disease in Korea: a nation-wide cohort study. Cancer Res Treat 2024;56: 1262\u20139.","DOI":"10.4143\/crt.2024.047"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Paetow, U, Bader, P, Chemaitilly, W. A systematic approach to the endocrine care of survivors of pediatric hematopoietic stem cell transplantation. Cancer Metastasis Rev 2020;39: 69\u201378.","DOI":"10.1007\/s10555-020-09864-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mayson, SE, Parker, VE, Schutta, MH, Semple, RK, Rickels, MR. Severe insulin resistance and hypertriglyceridemia after childhood total body irradiation. Endocr Pract 2013;19: 51\u20138.","DOI":"10.4158\/EP12115.OR"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Oudin, C, Auquier, P, Bertrand, Y, Contet, A, Kanold, J, Sirvent, N, et al. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study. Bone Marrow Transplant 2015;50: 1438\u201344.","DOI":"10.1038\/bmt.2015.167"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wei, C, Unsworth, R, Davis, N, Cox, R, Bradley, K, Stevens, M, et al. Survivors of childhood leukaemia treated with haematopoietic stem cell transplantation and total body irradiation should undergo screening for diabetes by oral glucose tolerance tests. Diabet Med 2016;33: 1347\u201351.","DOI":"10.1111\/dme.13060"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Nakagawa, R, Hosokawa-Tsuji, A, Aoki, Y, Takasawa, K, Maru, M, Nakajima, K, et al. Total body irradiation for hematopoietic stem cell transplantation during early childhood is associated with the risk for diabetes mellitus. Endocrine 2018;61: 76\u201382.","DOI":"10.1007\/s12020-018-1595-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rooney, DP, Ryan, MF. Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease. Diabet Med 2006;23: 436\u201340.","DOI":"10.1111\/j.1464-5491.2006.01855.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Adachi, M, Asakura, Y, Muroya, K, Goto, H, Kigasawa, H. Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy. Clin Pediatr Endocrinol 2013;22: 53\u201364.","DOI":"10.1297\/cpe.22.53"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kimura, L, Alvarez, G, Li, N, Pawlikowska-Haddal, A, Moore, TB, Casillas, J, et al. Temporary resolution of insulin requirement in acquired partial lipodystrophy associated with chronic graft-versus-host disease. Pediatr Blood Cancer 2017;64: .","DOI":"10.1002\/pbc.26427"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ceccarini, G, Ferrari, F, Santini, F. Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list. J Endocrinol Invest 2017;40: 1273\u20134.","DOI":"10.1007\/s40618-017-0731-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shibata, Y, Nakatsuka, A, Eguchi, J, Miyamoto, S, Masuda, Y, Awazawa, M, et al. Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports. J Med Case Rep 2018;12: 368.","DOI":"10.1186\/s13256-018-1901-y"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hosokawa, M, Shibata, H, Hosokawa, T, Irie, J, Ito, H, Hasegawa, T. Acquired partial lipodystrophy with metabolic disease in children following hematopoietic stem cell transplantation: a report of two cases and a review of the literature. J Pediatr Endocrinol Metab 2019;32: 537\u201341.","DOI":"10.1515\/jpem-2018-0356"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nagayama, A, Ashida, K, Moritaka, K, Hidaka, M, Gobaru, M, Tanaka, S, et al. Metreleptin supplementation for improving lipid and glycemic profiles in acquired diabetes lipodystrophy: a case report. J Endocr Soc 2019;3: 2179\u201383.","DOI":"10.1210\/js.2019-00251"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nagayama, A, Ashida, K, Watanabe, M, Moritaka, K, Sonezaki, A, Kitajima, Y, et al. Case report: metreleptin and SGLT2 inhibitor combination therapy is effective for acquired incomplete lipodystrophy. Front Endocrinol (Lausanne) 2021;12: 690996.","DOI":"10.3389\/fendo.2021.690996"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Akisada, H, Hasegawa, M, Ishihara, T, Akisada, N, Ochi, S, Nogami, K. Endocrine late effects in survivors of infantile acute lymphoblastic leukemia. Clin Pediatr Endocrinol 2023;32: 90\u20137.","DOI":"10.1297\/cpe.2022-0037"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Romanisio, M, Bighetti, L, Daffara, T, Mollero, ELM, Pelosini, C, Antoniotti, V, et al. Acquired partial lipodystrophy: clinical management in a pregnant patient. J Endocr Soc 2024;8: bvae181.","DOI":"10.1210\/jendso\/bvae181"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Khan, Z, Ali, K, Khan, A, Teelucksingh, S. A case of bone marrow transplant-associated partial lipodystrophy. Cureus 2024;16: e71641.","DOI":"10.7759\/cureus.71641"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ishida, E, Horiguchi, K, Matsumoto, S, Ozawa, A, Sekiguchi, S, Yamada, E. Influence of diet and body weight in treatment-resistant acquired partial lipodystrophy after hematopoietic stem cell transplantation and its potential for metabolic improvement. Diabetol Int 2023;15: 290\u20136.","DOI":"10.1007\/s13340-023-00674-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ancona, G. Clinical features of acquired lipodystrophy after total body irradiation: a case report and mini review. Curr Med Res Opin 2025;41: 627\u201337.","DOI":"10.1080\/03007995.2025.2475090"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Adachi, M, Muroya, K, Hanakawa, J, Asakura, Y. Metreleptin worked in a diabetic woman with a history of hematopoietic stem cell transplantation (HSCT) during infancy: further support for the concept of \u2018HSCT-associated lipodystrophy\u2019. Endocr J 2021;68: 399\u2013407.","DOI":"10.1507\/endocrj.EJ20-0325"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wysham, C, Hood, RC, Warren, ML, Wang, T, Morwick, TM, Jackson, JA. Effect of total daily dose om efficacy, dosing, and safety of 2 dose titration regimens of human regular U500 insulin in severely insulin-resistant patients with type 2 diabetes. Endocr Pract 2016;22: 653\u201365.","DOI":"10.4158\/EP15959.OR"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Chait, A. Hypertriglyceridemia. Endocrinol Metab Clin North Am 2022;51: 539\u201355.","DOI":"10.1016\/j.ecl.2022.02.010"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Esfandiari, NH, Rubenfire, M, Neidert, AH, Hench, R, Eldin, AJ, Meral, R, et al. Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin. Clin Diabetes Endocrinol 2019;5: 4.","DOI":"10.1186\/s40842-019-0076-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Agarwal, S, Bodansky, A, Xing, C, Anderson, MS, Garg, A. Partial lipodystrophy affecting the extremities in a young woman with autoimmune polyglandular syndrome 1. JCEM Case Rep 2024;2: luae166.","DOI":"10.1210\/jcemcr\/luae166"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Brown, RJ, Araujo-Vilar, D, Cheung, PT, Dunger, D, Garg, A, Jack, M, et al. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab 2016;101: 4500\u201311.","DOI":"10.1210\/jc.2016-2466"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Tanaka, T, Kusakabe, T, Ebihara, K, Aizawa-Abe, M, Aotani, D, Yorifuji, T, et al. Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES). Endocr J 2021;68: 1027\u201342.","DOI":"10.1507\/endocrj.EJ21-0110"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gilio, D, Foss-Freitas, M, Oral, EA. Clinical guidance for lipodystrophy syndromes: from diagnosis and work-up to treatment. Curr Diab Rep 2025;25: 47.","DOI":"10.1007\/s11892-025-01603-4"},{"key":"31","unstructured":"31. Akinci, B, Gular, MC, Oral, EA. Lipodystrophy syndromes: presentation and treatment. 2024 Aug 21. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, <i>et al<\/i>., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.;  2000\u2013. PMID: 29989768."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lima, JG, Valerio, CM, F Godoy-Matos, A, Carvalho, G, Dantas, JR, Nunes Salles, JE, et al. Pathways to improving the awareness, diagnosis and management of lipodystrophy in Brazil: an expert panel discussion. Diabetol Metab Syndr 2025;17: 438.","DOI":"10.1186\/s13098-025-01990-4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Brown, RJ, Akinci, B, Al Yaarubi, S, Bismuth, E, Cappa, M, Deeb, A, et al. The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions. Front Endocrinol (Lausanne) 2025;16: 1597053.","DOI":"10.3389\/fendo.2025.1597053"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Mainieri, F, Chiarelli, F. Lipodystrophies in children. Horm Res Paediatr 2022;95: 305\u201320.","DOI":"10.1159\/000522620"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Ara\u00fajo-Vilar, D, Santini, F. Diagnosis and treatment of lipodystrophy: a step-by-step approach. J Endocrinol Invest 2019;42: 61\u201373.","DOI":"10.1007\/s40618-018-0887-z"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Akinci, B, Meral, R, Oral, EA. Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities. Curr Diab Rep 2018;18: 143.","DOI":"10.1007\/s11892-018-1099-9"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ceccarini, G, Vatier, C, Akinci, B, Belalem, I, Broekema, M, Csajbok, E, et al. Epidemiological and clinical data from the European Lipodystrophy Registry. Eur J Endocrinol 2025;193: 685\u2013703.","DOI":"10.1093\/ejendo\/lvaf214"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Danforth, EFailure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 2000;26: 13.","DOI":"10.1038\/79111"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Neeland, IJ, Ross, R, Despr\u00e9s, JP, Matsuzawa, Y, Yamashita, S, Shai, I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 2019;7: 715\u201325.","DOI":"10.1016\/S2213-8587(19)30084-1"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Poglio, S, Galvani, S, Bour, S, Andr\u00e9, M, Prunet-Marcassus, B, P\u00e9nicaud, L, et al. Adipose tissue sensitivity to radiation exposure. Am J Pathol 2009;174: 44\u201353.","DOI":"10.2353\/ajpath.2009.080505"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Ablamunits, V, Weisberg, SP, Lemieux, JE, Combs, TP, Klebanov, S. Reduced adiposity in <i>ob\/ob<\/i> mice following total body irradiation and bone marrow transplantation. Obesity (Silver Spring) 2007;15: 1419\u201329.","DOI":"10.1038\/oby.2007.170"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Liermann-Wooldrik, KT, Kosmacek, EA, McDowell, JA, Takkar, S, Murthy, D, Singh, PK, et al. Radiation promotes acute and chronic damage to adipose tissue. Int J Mol Sci 2025;26: 5626.","DOI":"10.3390\/ijms26125626"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Wei, C, Thyagiarajan, MS, Hunt, LP, Shield, JP, Stevens, MC, Crowne, EC. Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes. Pediatr Blood Cancer 2015;62: 1992\u20139.","DOI":"10.1002\/pbc.25601"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Tews, D, Schulz, A, Denzer, C, von Schnurbein, J, Ceccarini, G, Debatin, KM, et al. Lipodystrophy as a late effect after stem cell transplantation. J Clin Med 2021;10: 1559.","DOI":"10.3390\/jcm10081559"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Gavin, KM, Gutman, JA, Kohrt, WM, Wei, Q, Shea, KL, Miller, HL, et al. De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue. FASEB J 2016;30: 1096\u2013108.","DOI":"10.1096\/fj.15-278994"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Lorenc, A, Hamilton-Shield, J, Perry, R, Stevens, M, CTYA HSCT Adipose and Muscle Late Effects Working Group. Body composition after allogeneic haematopoietic cell transplantation\/total body irradiation in children and young people: a restricted systematic review. J Cancer Surviv 2020;14: 624\u201342.","DOI":"10.1007\/s11764-020-00871-1"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Rajendran, R, Abu, E, Fadl, A, Byrne, CD. Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation. Diabet Med 2013;30: e239\u201342.","DOI":"10.1111\/dme.12234"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Lecoutre, S, Rebi\u00e8re, C, Maqdasy, S, Lambert, M, Dussaud, S, Abatan, JB, et al. Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health. Nat Rev Endocrinol 2025;21: 272\u201388.","DOI":"10.1038\/s41574-024-01071-y"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Schwalie, PC, Dong, H, Zachara, M, Russeil, J, Alpern, D, Akchiche, N, et al. A stromal cell population that inhibits adipogenesis in mammalian fat depots. Nature 2018;559: 103\u20138.","DOI":"10.1038\/s41586-018-0226-8"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Poissonnet, CM, Burdi, AR, Garn, SM. The chronology of adipose tissue appearance and distribution in the human fetus. Early Hum Dev 1984;10: 1\u201311.","DOI":"10.1016\/0378-3782(84)90106-3"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Knittle, JL, Timmers, K, Ginsberg-Fellner, F, Brown, RE, Katz, DP. The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J Clin Invest 1979;63: 239\u201346.","DOI":"10.1172\/JCI109295"},{"key":"52","doi-asserted-by":"publisher","unstructured":"52. Spalding, KL, Arner, E, Westermark, PO, Bernard, S, Buchholz, BA, Bergmann, O, et al. Dynamics of fat cell turnover in humans. Nature 2008;453: 783\u20137.","DOI":"10.1038\/nature06902"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Wang, G, Song, A, Wang, QA. Adipose tissue ageing: implications for metabolic health and lifespan. Nat Rev Endocrinol 2025;21: 623\u201337.","DOI":"10.1038\/s41574-025-01142-8"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Jo, SK, Seol, MA, Park, HR, Jung, U, Roh, C. Ionising radiation triggers fat accumulation in white adipose tissue. Int J Radiat Biol 2011;87: 302\u201310.","DOI":"10.3109\/09553002.2010.537429"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Shreder, K, Rapp, F, Tsoukala, I, Rzeznik, V, Wabitsch, M, Fischer-Posovszky, P, et al. Impact of X-ray exposure on the proliferation and differentiation of human pre-adipocytes. Int J Mol Sci 2018;19: 2717.","DOI":"10.3390\/ijms19092717"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Lo, WJ, Lin, CL, Chang, YC, Bai, LY, Lin, CY, Liang, JA, et al. Total body irradiation tremendously impair the proliferation, differentiation and chromosomal integrity of bone marrow-derived mesenchymal stromal stem cells. Ann Hematol 2018;97: 697\u2013707.","DOI":"10.1007\/s00277-018-3231-y"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Visentin, S, Michel, G, Oudin, C, Cousin, B, Gaborit, B, Abdesselam, I, et al. Lipodystrophy-like features after total body irradiation among survivors of childhood acute leukemia. Endocr Connect 2019;8: 349\u201359.","DOI":"10.1530\/EC-18-0497"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Yeh, JM, Ward, ZJ, Stratton, KL, McMahon, MV, Taylor, CS, Armstrong, GT, et al. Accelerated aging in survivors of childhood cancer - early onset and excess risk of chronic conditions. JAMA Oncol 2025;11: 535\u201343.","DOI":"10.1001\/jamaoncol.2025.0236"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Wang, S, El Jurdi, N, Thyagarajan, B, Prizment, A, Blaes, AH. Accelerated aging in cancer survivors: cellular senescence, frailty, and possible opportunities for interventions. Int J Mol Sci 2024;25: 3319.","DOI":"10.3390\/ijms25063319"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. L\u00e1zni\u010dkov\u00e1, P, Bend\u00ed\u010dkov\u00e1, K, Kep\u00e1k, T, Fri\u010d, J. Immunosenescence in childhood cancer survivors and in elderly: a comparison and implication for risk stratification. Front Aging 2021;2: 708788.","DOI":"10.3389\/fragi.2021.708788"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Gazzaruso, C, Gola, M, Karamouzis, I, Giubbini, R, Giustina, A. Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update. J Clin Endocrinol Metab 2014;99: 18\u201329.","DOI":"10.1210\/jc.2013-2394"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Garg, A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 2000;85: 1776\u201382.","DOI":"10.1210\/jcem.85.5.6605"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Kruglikov, IL, Joffin, N, Scherer, PE. The MMP14-caveolin axis and its potential relevance for lipoedema. Nat Rev Endocrinol 2020;16: 669\u201374.","DOI":"10.1038\/s41574-020-0395-z"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Goossens, GH, Jocken, JWE, Blaak, EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol 2021;17: 47\u201366.","DOI":"10.1038\/s41574-020-00431-8"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Vieira-Potter, VJ, Mishra, G, Townsend, KL. Health of adipose tissue: oestrogen matters. Nat Rev Endocrinol 2026;22: 76\u201391.","DOI":"10.1038\/s41574-025-01180-2"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Saxena, A, Tiwari, P, Wahi, N, Kumar, A, Mathur, SK. The common pathophysiologic threads between Asian Indian diabetic\u2019s \u2018Thin Fat Phenotype\u2019 and partial lipodystrophy: the peripheral adipose tissue transcriptomic evidences. Adipocyte 2020;9: 253\u201363.","DOI":"10.1080\/21623945.2020.1776082"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Hodgson, S, Williamson, A, Bigossi, M, Stow, D, Jacobs, BM, Samuel, M, et al. Genetic basis of early onset and progression of type 2 diabetes in South Asians. Nat Med 2025;31: 323\u201331.","DOI":"10.1038\/s41591-024-03317-8"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Adachi, M, Oto, Y, Muroya, K, Hanakawa, J, Asakura, Y, Goto, H. Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey. Clin Pediatr Endocrinol 2017;26: 99\u2013108.","DOI":"10.1297\/cpe.26.99"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Adiyaman, SC, Altay, C, Kamisli, BY, Avci, ER, Basara, I, Simsir, IY, et al. Pelvis magnetic resonance imaging to diagnose familial partial lipodystrophy. J Clin Endocrinol Metab 2023;108: e512\u201320.","DOI":"10.1210\/clinem\/dgad063"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. J\u00e9ru, I, Vatier, C, Araujo-Vilar, D, Vigouroux, C, Lascols, O. Clinical utility gene card for: familial partial lipodystrophy. Eur J Hum Genet 2017;25: .","DOI":"10.1038\/ejhg.2016.102"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Mosbah, H, Vatier, C, Vigouroux, C. Partial lipodystrophy: Clinical presentation and treatment. Ann Endocrinol (Paris) 2024;85: 197\u2013200.","DOI":"10.1016\/j.ando.2024.05.015"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Barrea, L, Verde, L, Colao, A, Mandarino, LJ, Muscogiuri, G. Medical nutrition therapy for the management of type 2 diabetes mellitus. Nat Rev Endocrinol 2025;21: 769\u201382.","DOI":"10.1038\/s41574-025-01161-5"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Al-Mhanna, SB, Batrakoulis, A, Wan Ghazali, WS, Mohamed, M, Aldayel, A, Alhussain, MH, et al. Effects of combined aerobic and resistance training on glycemic control, blood pressure, inflammation, cardiorespiratory fitness and quality of life in patients with type 2 diabetes and overweight\/obesity: a systematic review and meta-analysis. PeerJ 2024;12: e17525.","DOI":"10.7717\/peerj.17525"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Chaib, S, Palmer, AK, Wyles, SP, Musi, N, Kirkland, JL, Tchkonia, T. Translating cellular senescence research into clinical practice for metabolic disease. Nat Rev Endocrinol 2026;22: 102\u201315.","DOI":"10.1038\/s41574-025-01187-9"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Arioglu, E, Duncan-Morin, J, Sebring, N, Rother, KI, Gottlieb, N, Lieberman, J, et al. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med 2000;133: 263\u201374.","DOI":"10.7326\/0003-4819-133-4-200008150-00009"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Lee, YH, Lim, S, Davies, MJ. Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors. Nat Rev Endocrinol 2025;21: 783\u201398.","DOI":"10.1038\/s41574-025-01170-4"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Lamothe, S, Belalem, I, Vantyghem, MC, Nobecourt, E, Mosbah, H, B\u00e9liard, S, et al. Safety and effectiveness in an uncontrolled setting of glucagon-like-peptide-1 receptor agonists in patients with familial partial lipodystrophy: Real-life experience from a national reference network. Diabetes Obes Metab 2025;27: 1815\u201325.","DOI":"10.1111\/dom.16175"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Satoh, M, Yoshizawa, A, Takesue, M, Saji, T, Yokoya, S. Long-term effects of recombinant human insulin-like growth factor I treatment on glucose and lipid metabolism and the growth of a patient with congenital generalized lipodystrophy. Endocr J 2006;53: 639\u201345.","DOI":"10.1507\/endocrj.K06-014"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Hamam, M, Eyuboglu, AA, Isken, MT. Barraquer Simons syndrome: case series and review of surgical treatments for facial lipodystrophy. Aesthetic Plast Surg 2025;49: 4139\u201355.","DOI":"10.1007\/s00266-025-04794-z"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Lin, EW, Brady, GF, Kwan, R, Nesvizhskii, AI, Omary, MB. Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation. FASEB J 2020;34: 9051\u201373.","DOI":"10.1096\/fj.202000500R"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Elzeneini, E, Wickstr\u00f6m, SA. Lipodystrophic laminopathy: Lamin A mutation relaxes chromatin architecture to impair adipogenesis. J Cell Biol 2017;216: 2607\u201310.","DOI":"10.1083\/jcb.201707090"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Billon, N, Iannarelli, P, Monteiro, MC, Glavieux-Pardanaud, C, Richardson, WD, Kessaris, N, et al. The generation of adipocytes by the neural crest. Development 2007;134: 2283\u201392.","DOI":"10.1242\/dev.002642"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. B\u00e4ckdahl, J, Franz\u00e9n, L, Massier, L, Li, Q, Jalkanen, J, Gao, H, et al. Spatial mapping reveals human adipocyte subpopulations with distinct sensitivities to insulin. Cell Metab 2021;33: 1869\u20131882.e6.","DOI":"10.1016\/j.cmet.2021.07.018"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Kuo, FC, Neville, MJ, Sabaratnam, R, Wesolowska-Andersen, A, Phillips, D, Wittemans, LBL, et al. HOTAIR interacts with PRC2 complex regulating the regional preadipocyte transcriptome and human fat distribution. Cell Rep 2022;40: 111136.","DOI":"10.1016\/j.celrep.2022.111136"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Camastra, S, Ferrannini, E. Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review. Rev Endocr Metab Disord 2022;23: 43\u201350.","DOI":"10.1007\/s11154-021-09708-3"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Divoux, A, Whytock, KL, Halasz, L, Hopf, ME, Sparks, LM, Osborne, TF, et al. Distinct subpopulations of human subcutaneous adipose tissue precursor cells revealed by single-cell RNA sequencing. Am J Physiol Cell Physiol 2024;326: C1248\u201361.","DOI":"10.1152\/ajpcell.00726.2023"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Zichov\u00e1, A, Eckschlager, T, Ganevov\u00e1, M, Malinov\u00e1, B, Luk\u0161, A, Kruseov\u00e1, J. Subsequent neoplasms in childhood cancer survivors. Cancer Epidemiol 2020;68: 101779.","DOI":"10.1016\/j.canep.2020.101779"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Brown, RJ, Araujo-Vilar, D, Walkovich, KJ, Barbarosie, A, Magee, DA, Akinci, B, et al. A real-world pharmacovigilance assessment and literature review of lymphoma development in lipodystrophy. Front Endocrinol (Lausanne) 2025;16: 1582715.","DOI":"10.3389\/fendo.2025.1582715"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Youssef, SJ, Macielak, RJ, Schimmenti, LA, Chatzopoulos, K, Price, DL. Hypopharyngeal squamous cell carcinoma in sisters with LMNA associated familial partial lipodystrophy: a case report and review of the literature. Ann Otol Rhinol Laryngol 2020;129: 1243\u20136.","DOI":"10.1177\/0003489420933645"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Meng, Z, Liu, C, Xu, M, Tao, Y, Li, H, Wang, X, et al. Adipose transplantation improves metabolism and atherosclerosis but not perivascular adipose tissue abnormality or vascular dysfunction in lipodystrophic <i>Seipin\/Apoe<\/i> null mice. Am J Physiol Cell Physiol 2024;326: C1410\u201322.","DOI":"10.1152\/ajpcell.00698.2023"},{"key":"91","unstructured":"91. Verhaegen, AA, Van Gaal, LF. Drugs that affect body weight, body fat distribution, and metabolism. 2019 Feb 11. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, <i>et al<\/i>., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.;  2000\u2013."},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Lecka-Czernik, B, Rosen, CJ, Napoli, N. The role of bone in whole-body energy metabolism. Nat Rev Endocrinol 2025;21: 743\u201356.","DOI":"10.1038\/s41574-025-01162-4"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Foss-Freitas, MC, Akinci, B, Neidert, A, Bartlett, VJ, Hurh, E, Karwatowska-Prokopczuk, E, et al. Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study. Lipids Health Dis 2021;20: 174.","DOI":"10.1186\/s12944-021-01589-4"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Sanchez, GAM, Reinhardt, A, Ramsey, S, Wittkowski, H, Hashkes, PJ, Berkun, Y, et al. JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest 2018;128: 3041\u201352.","DOI":"10.1172\/JCI98814"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/35\/3\/35_2026-0005\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:24:04Z","timestamp":1783743844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/35\/3\/35_2026-0005\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2026-0005","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2026-0005"}}